{"disease":{"id":"stargardt-disease-3","name":"stargardt disease 3"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04281732","title":"Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT00420602","title":"DHA Supplementation in Patients With STGD3","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Utah","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}